糖尿病診斷市場：按產品類型、檢測類型、診斷技術、糖尿病類型和最終用戶分類

預計到2026年，糖尿病診斷市場規模將達到369.8億美元，2033年將達到637.9億美元。預計從2026年到2033年，該市場將以8.1%的複合年成長率成長。

全球糖尿病診斷市場是醫療保健領域的重要組成部分，專注於糖尿病的檢測、監測和管理。糖尿病是一種慢性代謝性疾病，影響全球數億人。該市場涵蓋了各種診斷工具、技術和調查方法，旨在識別糖尿病前期、診斷各種類型的糖尿病，並持續監測糖尿病患者的血糖值。

診斷領域涵蓋傳統血糖值儀、先進的連續血糖監測系統、糖化血紅蛋白A1c檢測設備、酮體試紙以及新興的就地檢驗解決方案。隨著久坐不動的生活方式、肥胖、老化和飲食結構的改變導致全球糖尿病盛行率不斷上升，對精準、高效且易於使用的診斷解決方案的需求持續成長。醫護人員、病患和看護者越來越依賴具備即時監測功能、更高準確性和更強連接性的先進診斷技術。該市場服務於各種醫療機構，從醫院和診斷檢查室到居家照護環境，致力於在全球範圍內幫助不同人群早期發現並有效管理糖尿病，從而預防併發症並改善患者預後。

市場動態

全球糖尿病診斷市場受多種關鍵因素驅動，呈現強勁成長動能。其中最主要的因素是全球糖尿病盛行率的驚人上升，尤其是第2型糖尿病，這主要歸因於生活方式的改變、都市化進程的加速以及各年齡層的肥胖率上升。診斷設備的科技進步，例如非侵入性血糖監測系統、智慧型手機連接設備和人工智慧（AI）診斷工具的開發，透過提高診斷的準確性、便利性和患者依從性，顯著推動了市場擴張。

新興經濟體政府為提高糖尿病意識、篩檢計畫和發展醫療基礎設施所採取的舉措，正在創造巨大的市場機會。同時，全球人口老化自然導致需要定期診斷監測的患者數量增加。然而，市場也存在著許多限制因素。先進診斷設備和連續監測系統的高成本限制了其普及，尤其是在低收入地區和未投保者中。醫療設備核准的嚴格監管要求導致研發週期漫長，並為製造商設置了巨大的投資障礙。此外，儘管開發中國家糖尿病盛行率高，但醫療基礎設施不足，限制了市場滲透率。另外，連網診斷設備的資料隱私和網路安全問題也對設備的廣泛應用構成挑戰。

儘管有這些限制，但隨著居家診斷解決方案需求的成長、遠端醫療平台與診斷設備的融合，以及對預防醫學日益重視（強調早期檢測和持續監測），巨大的機會正在湧現。這為開發經濟高效、精準易用診斷解決方案的創新公司帶來了盈利前景。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數對全球糖尿病診斷市場的主要參與者進行了分析：公司亮點、產品系列、關鍵亮點、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
• 這份全球糖尿病診斷市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
• 透過各種用於分析全球糖尿病診斷市場的策略矩陣，相關人員將能夠更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球糖尿病診斷市場：依產品類型分類，2021-2033年

• 血糖儀
• 連續血糖監測（CGM）系統
• 試紙
• 採血針及穿刺裝置
• HbA1c檢測套組
• 酮體檢測套組
• 胰島素劑量計算器/胰島素輸注裝置
• 其他（例如，智慧型穿戴裝置、新興數位診斷工具）

第5章 全球糖尿病診斷市場：依檢測類型分類，2021-2033年

• 自我血糖監測（SMBG）測試
• 檢查室檢測
• 即時偵測 (POC)

第6章 全球糖尿病診斷市場：依診斷技術分類，2021-2033年

• 電化學生物感測器
• 光學感測器
• 酵素法
• 免疫檢測
• 微流體技術
• 其他（例如，基於下一代奈米技術的診斷方法）

第7章 全球糖尿病診斷市場：依糖尿病類型分類，2021-2033年

• 1型糖尿病
• 2型糖尿病
• 妊娠糖尿病
• 糖尿病前期/篩檢

第8章 全球糖尿病診斷市場：依最終使用者分類，2021-2033年

• 醫院和診所
• 診斷檢查室
• 居家醫療
• 門診手術中心（ASC）
• 其他（研究機構和學術機構）

第9章 全球糖尿病診斷市場：依通路分類，2021-2033年

• 醫院藥房
• 零售藥房
• 網路藥房

第10章 全球糖尿病診斷市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第11章 競爭格局

• Abbott
• Roche Diagnostics
• Dexcom
• Medtronic
• LifeScan
• Ascensia Diabetes Care
• ARKRAY
• i-SENS
• Sinocare
• Bio-Rad Laboratories
• Tosoh Bioscience
• Siemens Healthineers
• Trinity Biotech
• EKF Diagnostics
• Senseonics

第12章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第13章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Diabetes Diagnostics Market is estimated to be valued at USD 36.98 Bn in 2026 and is expected to reach USD 63.79 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.1% from 2026 to 2033.

The global diabetes diagnostics market represents a critical healthcare segment focused on the detection, monitoring, and management of diabetes mellitus, a chronic metabolic disorder affecting hundreds of millions worldwide. This market encompasses a comprehensive range of diagnostic tools, technologies, and testing methodologies designed to identify pre-diabetic conditions, diagnose various types of diabetes, and continuously monitor blood glucose levels in diabetic patients.

The diagnostic landscape includes traditional glucose monitoring devices, advanced continuous glucose monitoring systems, hemoglobin A1c testing equipment, ketone testing strips, and emerging point-of-care testing solutions. With the rising global prevalence of diabetes driven by sedentary lifestyles, obesity, aging populations, and dietary changes, the demand for accurate, efficient, and user-friendly diagnostic solutions continues to escalate. Healthcare providers, patients, and caregivers increasingly rely on sophisticated diagnostic technologies that offer real-time monitoring capabilities, improved accuracy, and enhanced connectivity features. The market serves diverse healthcare settings ranging from hospitals and diagnostic laboratories to home-care environments, facilitating early detection and effective management of diabetes to prevent complications and improve patient outcomes across different demographic segments worldwide.

Market Dynamics

The global diabetes diagnostics market is propelled by several key drivers that sustain its robust growth trajectory, with the primary catalyst being the alarming rise in diabetes prevalence globally, particularly Type 2 diabetes, driven by lifestyle changes, urbanization, and increasing obesity rates across all age groups. Technological advancements in diagnostic equipment, including the development of non-invasive glucose monitoring systems, smartphone-integrated devices, and artificial intelligence-powered diagnostic tools, significantly enhance market expansion by improving accuracy, convenience, and patient compliance.

Government initiatives promoting diabetes awareness, screening programs, and healthcare infrastructure development in emerging economies create substantial market opportunities, while aging populations worldwide naturally increase the patient pool requiring regular diagnostic monitoring. However, the market faces notable restraints including high costs associated with advanced diagnostic equipment and continuous monitoring systems, which limit accessibility particularly in low-income regions and among uninsured populations. Stringent regulatory requirements for medical device approvals create lengthy development timelines and substantial investment barriers for manufacturers, while limited healthcare infrastructure in developing countries restricts market penetration despite high disease prevalence. Additionally, concerns regarding data privacy and cybersecurity in connected diagnostic devices pose challenges for widespread adoption.

Despite these constraints, significant opportunities emerge through the growing demand for home-based diagnostic solutions, integration of telemedicine platforms with diagnostic devices, and the expanding focus on preventive healthcare measures that emphasize early detection and continuous monitoring, creating lucrative prospects for innovative companies developing cost-effective, accurate, and user-friendly diagnostic solutions.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global diabetes diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include leading manufacturers and technology providers in the diabetes diagnostics space.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global diabetes diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes diagnostics market.

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2021 - 2033)
• Blood Glucose Meters
• Continuous Glucose Monitoring (CGM) Systems
• Testing Strips
• Lancets and Lancing Devices
• HbA1c Testing Kits
• Ketone Testing Kits
• Insulin Dose Calculators/Insulin Delivery Devices
• Others (e.g., smart wearables, emerging digital diagnostic tools)
• Testing Type Insights (Revenue, USD Bn, 2021 - 2033)
• Self-Monitoring Blood Glucose (SMBG) Tests
• Laboratory-Based Tests
• Point-of-Care (POC) Tests
• Diagnostic Technology Insights (Revenue, USD Bn, 2021 - 2033)
• Electrochemical Biosensors
• Optical Sensors
• Enzymatic Assays
• Immunoassays
• Microfluidic Technology
• Others (e.g., next-gen nanotechnology-based diagnostics)
• Diabetes Type Insights (Revenue, USD Bn, 2021 - 2033)
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Prediabetes/Screening
• End User Insights (Revenue, USD Bn, 2021 - 2033)
• Hospitals and Clinics
• Diagnostic Laboratories
• Home Care Settings
• Ambulatory Surgical Centers (ASCs)
• Others (Research Institutes and Academic Centers)
• Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Abbott
• Roche Diagnostics
• Dexcom
• Medtronic
• LifeScan
• Ascensia Diabetes Care
• ARKRAY
• i-SENS
• Sinocare
• Bio-Rad Laboratories
• Tosoh Bioscience
• Siemens Healthineers
• Trinity Biotech
• EKF Diagnostics
• Senseonics

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Diabetes Diagnostics Market, By Product Type
  • Global Diabetes Diagnostics Market, By Testing Type
  • Global Diabetes Diagnostics Market, By Diagnostic Technology
  • Global Diabetes Diagnostics Market, By Diabetes Type
  • Global Diabetes Diagnostics Market, By End User
  • Global Diabetes Diagnostics Market, By Distribution Channel
  • Global Diabetes Diagnostics Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Driver
  • Restraint
  • Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Diabetes Diagnostics Market, By Product Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Blood Glucose Meters
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Continuous Glucose Monitoring (CGM) Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Testing Strips
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Lancets and Lancing Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• HbA1c Testing Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Ketone Testing Kits
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Insulin Dose Calculators/Insulin Delivery Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others (e.g., smart wearables, emerging digital diagnostic tools)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Diabetes Diagnostics Market, By Testing Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Self-Monitoring Blood Glucose (SMBG) Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Laboratory-Based Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Point-of-Care (POC) Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Diabetes Diagnostics Market, By Diagnostic Technology, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Electrochemical Biosensors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Optical Sensors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Enzymatic Assays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Immunoassays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Microfluidic Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others (e.g., next-gen nanotechnology-based diagnostics)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Diabetes Diagnostics Market, By Diabetes Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Type 1 Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Type 2 Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Gestational Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Prediabetes/Screening
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Diabetes Diagnostics Market, By End User, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospitals and Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Diagnostic Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Ambulatory Surgical Centers (ASCs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others (Research Institutes and Academic Centers)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Diabetes Diagnostics Market, By Distribution Channel, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Diabetes Diagnostics Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Testing Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Diagnostic Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Testing Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Diagnostic Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Testing Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Diagnostic Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Testing Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Diagnostic Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Testing Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Diagnostic Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Testing Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Diagnostic Technology, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Diabetes Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

11. Competitive Landscape

• Abbott
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Roche Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Dexcom
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• LifeScan
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ascensia Diabetes Care
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ARKRAY
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• i-SENS
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sinocare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Tosoh Bioscience
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Trinity Biotech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• EKF Diagnostics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Senseonics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

12. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

13. References and Research Methodology

• References
• Research Methodology
• About us